Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at the Cantor Fitzgerald Inaugural Healthcare Conference as follows:
| Date: | Wednesday, July 8, 2015 | |||
| Time: | 3:45 p.m. EDT | |||
| Location: | Le Parker Meridien Hotel, New York City |
The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section or click here.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.
In-Site Communications, Inc.
Lisa M. Wilson
President
212-452-2793